Publications
5674 Results
- Journal / Conference
- Journal of Clinical Oncology 29: 2011 (suppl; abstr 1004); ASCO 2011 meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
First analysis of SWOG S0221: A phase III trial comparing chemotherapy schedules in high risk early breast cancer
- Journal / Conference
- Journal of Clinical Oncology 29: 2011 (suppl; abstr TPS104); ASCO Meeting, TIP poster
- Year
- 2011
- Research Committee(s)
- Breast
- Study Number(s)
- S1007
SWOG S1007: a phase III, randomized clinical trial of standard adjuvant endocrine therapy +/- chemotherapy in patients with 1-2 positive nodes, hormone receptor (HR)-positive and HER2-negative breast cancer with recurrence score (RS) of 25 or less
- Journal / Conference
- Journal of Clinical Oncology 29: 2011 (suppl; abstr 7040); ASCO 2011 meeting, general poster presentation
- Year
- 2011
- Research Committee(s)
- Lung
- Study Number(s)
- S0429
Pilot study (SWOG S0429) of weekly cetuximab and chest radiotherapy (RT) for poor-risk stage III non-small cell lung cancer (NSCLC)
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl; abstr 6564) ASCO 2011 meeting, general poster presentation
- Year
- 2011
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500
Expression of topoisomerase II isoforms a and B in adult patients with acute myeloid leukemia (AML): relationship to immunophenotype and treatment outcome
- Journal / Conference
- American Journal of Respiratory & Critical Care Medicine 183:A6419:2011; American Thoracic Society 2011 Meeting, poster discussion;
- Year
- 2011
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000C
Effect of vitamin E and selenium on rate of decline in FEV1: the respiratory ancillary study to the Selenium and Vitamin E Cancer Prevention Trial (SELECT)
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl; abstr 8001); ASCO 2011 Annual Meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S9704
Randomized phase III US/Canadian intergroup trial (SWOG S9704) comparing CHOP+/- R x 8 vs. CHOP +/- R x 6 followed by high dose therapy and autotransplant for patients with diffuse aggressive non-Hodgkin's lymphoma (NHL) in the high-intermediate (H-Int) or high IPI risk groups
- Journal / Conference
- Journal of Clinical Oncology 29:(suppl; abstr 7013)ASCO 2011 Annual Meeting, poster discussion presentation
- Year
- 2011
- Research Committee(s)
- Lung
- Study Number(s)
- CTSU/E1505
Interim report of on-study demographics and toxicity from E1505, a phase III randomized trial of adjuvant (adj) chemotherapy (chemo) with or without bevacizumab (B) for completely resected early stage non-small cell lung cancer (NSCLC)
- Journal / Conference
- International Conference on Malignant Lymphoma, poster presentation
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E4494
Gene expression profiling using paraffin-embedded tissues and the nuclease protection assay in diffuse large B-cell lymphoma (DLBCL) treated with CHOP or R-CHOP: an ECOG and SWOG correlative study of E4494
- Journal / Conference
- Lancet 378(9790):507-514;
- Year
- 2011
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0701
14-day triple, 5-day concomitant, and 10-day sequential therapies for helicobacter pylori infection in seven Latin American sites: a randomised trial [PMID:21777974;PMC3313469]
- Journal / Conference
- Journal of Clinical Oncology 29(25):3443-3449;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- 4B951